Inovio Pharma (INO) Tops Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $0.77 --0%
Financial Fact:
Loss from investment in affiliated entity: -958.14K
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
Loss from investment in affiliated entity: -958.14K
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($1.10), $0.13 better than the analyst estimate of ($1.23). Revenue for the quarter came in at $103 million versus the consensus estimate of $217.65 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
- Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
